High-income countries that initiated widespread administration of the human papillomavirus (HPV) vaccine in the mid-2000s have experienced substantial declines in cervical cancer cases, marking a significant achievement in medicine.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗